Antibiotics, Antineoplastic - Research News and Information

Wednesday, January 07, 2009

Preliminary study of fibrin glue combined with pingyangmycin for the treatment of venous malformations in the oral and maxillofacial region.

30 Oct 2008 PURPOSE: To observe the outcome of using fibrin glue (FG) combined with Pingyangmycin (Tianjin Taihe Pharmaceutical Co Ltd, Tianjin, China) in the treatment of venous malformations (VMs) in the oral and maxillofacial region. MATERIALS AND METHODS: ... Read more...

Reversible derivatization to enhance enzymatic synthesis: chemoenzymatic synthesis of doxorubicin-14-O-esters.

13 Oct 2008 An efficient three-step, chemoenzymatic synthesis of unprotected doxorubicin-14-O-esters from doxorubicin hydrochloride salt is described. The key step is a lipase-catalyzed regioselective transesterification/esterification using commercially ... Read more...

[Effective PAD (bortezomib, doxorubicin, dexamethasone) treatment of a patient with plasma cell leukaemia that has developed after autologous stem cell transplantation]

10 Oct 2008 The most aggressive and rare manifestation of multiple myeloma is plasma cell leukaemia (PCL). While secondary form of PCL represents those heavily pretreated cases when leukaemic transformation develops terminally after intensive chemotherapy in ... Read more...

Learn Faster Today      Improve your study skills

Latest indexed articles for 'Antibiotics, Antineoplastic'

These are the very latest articles for this heading:

• Preliminary study of fibrin glue combined with pingyangmycin for the treatment of venous malformations in the oral and maxillofacial region. 30 Oct 2008
• Reversible derivatization to enhance enzymatic synthesis: chemoenzymatic synthesis of doxorubicin-14-O-esters. 13 Oct 2008
• [Effective PAD (bortezomib, doxorubicin, dexamethasone) treatment of a patient with plasma cell leukaemia that has developed after autologous stem cell transplantation] 10 Oct 2008
• Folate-functionalized polymeric micelle as hepatic carcinoma-targeted, MRI-ultrasensitive delivery system of antitumor drugs. 29 Sep 2008
• Prediction of doxorubicin sensitivity in gastric cancers based on a set of novel markers. 29 Sep 2008
• Vesicoenteric, vesicovaginal, vesicocutaneous fistula -an unusual complication with intravesical mitomycin. 29 Sep 2008
• Possible involvement of long chain fatty acids in the spores of Ganoderma lucidum (Reishi Houshi) to its anti-tumor activity. 29 Sep 2008
• Eccrine squamous syringometaplasia secondary to pegylated liposomal doxorubicin. 29 Sep 2008
• Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice. 4-year results from a large 2-institutional cohort study. 28 Sep 2008
• Superoxide anions regulate TORC1 and its ability to bind Fpr1:rapamycin complex. 21 Sep 2008
• Hydration of drug-DNA complexes: greater water uptake for adriamycin compared to daunomycin. 11 Sep 2008
• Combined effects of p53 gene therapy and leptomycin B in human esophageal squamous cell carcinoma. 9 Sep 2008
• Primary Kaposi sarcoma of the subcutaneous tissue. 31 Aug 2008
• Chemotherapy for breast cancer during pregnancy: is epirubicin safe? 31 Aug 2008
• Anthracyclines: the first generation of cytotoxic targeted agents? A possible dream. 31 Aug 2008
• Type 1 receptor tyrosine kinase profiles identify patients with enhanced benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial. 31 Aug 2008
• Transcatheter chemoembolization in the treatment of HCC in patients not eligible for curative treatments: midterm results of doxorubicin-loaded DC bead. 30 Aug 2008
• Adriamycin induces H2AX phosphorylation in human spermatozoa. 30 Aug 2008
• GFP image analysis in the mouse orthotopic bladder cancer model. 30 Aug 2008
• Linalool, a plant-derived monoterpene alcohol, reverses doxorubicin resistance in human breast adenocarcinoma cells. 30 Aug 2008

See a longer list of these articles.

Technical information about 'Antibiotics, Antineoplastic'

Definition: Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms.

Registry Number: 0

Descriptor UI: D000903

Alternative terms: Antibiotics, Antineoplastic; Antineoplastic Antibiotics; Antibiotics, Cytotoxic; Cytotoxic Antibiotics;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D27.505.954.248.106;

History Note: 67

Technical Notes: GEN: prefer specifics